Sprout Pharmaceuticals aims for October 17 release of its once-daily drug for hypoactive sexual desire disorder in premenopausal women. As expected, the FDA required the company to include significant warnings of interactions with alcohol and other drugs.

from Forbes – Tech http://ift.tt/1K4FXZr
via IFTTT